DelveInsight’s “Marburg Virus Disease- Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Marburg Virus Disease, historical and forecasted epidemiology as well as the Marburg Virus Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Marburg Virus Disease market report provides current treatment practices, emerging drugs, Marburg Virus Disease market share of the individual therapies, and current and forecasted Marburg Virus Disease market size from 2019 to 2032 segmented by seven major markets. The Report also covers current Marburg Virus Disease treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities. It assesses the underlying potential of the market.
Some of the Key Facts of the Marburg Virus Disease Market Report:
-
Marburg virus disease (MVD), formerly known as Marburg hemorrhagic fever, is a severe, often fatal illness in humans.
-
The virus causes severe viral hemorrhagic fever in humans.
-
The average MVD case fatality rate is around 50%. Case fatality rates have varied from 24% to 88% in past outbreaks depending on virus strain and case management.
Key Benefits of the Marburg Virus Disease Market Report
-
The report covers the descriptive overview of Marburg Virus Disease, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
-
Comprehensive insight has been provided into the Marburg Virus Disease epidemiology and treatment in the 7MM
-
Additionally, an all-inclusive account of both the current and emerging therapies for Marburg Virus Disease are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
-
A detailed review of Marburg Virus Disease market; historical and forecasted is included in the report, covering drug outreach in the 7MM
-
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Marburg Virus Disease market
Got queries? Click here to know more about the Marburg Virus Disease Market Landscape
Marburg Virus Disease Overview
Marburg virus disease (MVD) is a rare but severe hemorrhagic fever which affects both people and non-human primates. MVD is caused by the Marburg virus, a genetically unique zoonotic (or, animal-borne) RNA virus of the filovirus family. The six species of Ebola virus are the only other known members of the filovirus family.
Marburg virus was first recognized in 1967, when outbreaks of hemorrhagic fever occurred simultaneously in laboratories in Marburg and Frankfurt, Germany and in Belgrade, Yugoslavia (now Serbia). Thirty-one people became ill, initially laboratory workers followed by several medical personnel and family members who had cared for them. Seven deaths were reported. The first people infected had been exposed to Ugandan imported African green monkeys or their tissues while conducting research. One additional case was diagnosed retrospectively.
Marburg Virus Disease Epidemiological Insights:
-
Outbreaks and sporadic cases have been reported in Angola, the Democratic Republic of Congo, Kenya, Ghana, Guinea, Uganda, and South Africa (in a person who had recently traveled to Zimbabwe).
-
The largest outbreak on record to date occurred in 2005 in Angola and involved 374 cases, including 329 deaths.
-
Two unrelated sporadic cases in travelers occurred during 2008 following visits to the ‘python cave’ in the Maramagambo Forest in western Uganda; this cave is home to a large colony of Egyptian fruit bats. Both people became ill upon return to their home country; one in the Netherlands and one in the USA.
-
In October 2017, 3 fatal cases of MVD were reported in eastern Uganda, near the Kenyan border.
Marburg Virus Disease Epidemiological Segmentation
-
Total Marburg Virus Disease prevelant cases
-
Total Marburg Virus Disease diagnosed Cases
-
Total Marburg Virus Disease treatment cases
Marburg Virus Disease Market Outlook
The Marburg Virus Disease market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted Marburg Virus Disease market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
This segment gives a thorough detail of the Marburg Virus Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Marburg Virus Disease market in 7MM is expected to change in the study period 2019-2032.
Learn more by requesting for sample @ Marburg Virus Disease Market Landscape
Table of Contents
-
Key Insights
-
Report Introduction
-
Executive Summary of Marburg Virus Disease
-
Disease Background and Overview
-
Epidemiology and patient population
-
The United States
-
EU 5
-
Marburg Virus Disease Emerging Therapies
-
Marburg Virus Disease Market Outlook
-
Market Drivers
-
Market Barriers
-
Market Access and Reimbursement of Therapies
-
Appendix
-
Marburg Virus Disease Report Methodology
-
DelveInsight Capabilities
-
Disclaimer
-
About DelveInsight
Click here to read more about Marburg Virus Disease Market Landscape
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com